Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Post-translational modifications of hemoglobin.

H F Bunn

    Haematologia
    |January 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Hemoglobin modifications, like glycosylation (HbA1c), reveal metabolic disorders. These adducts serve as vital biomarkers for monitoring conditions such as diabetes and uremia.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Signal transduction. How do cells sense oxygen?

    Science (New York, N.Y.)·2001
    Same author

    Cadmium and platinum suppression of erythropoietin production in cell culture: clinical implications.

    Blood·2000
    Same author

    Identification of a cytochrome b-type NAD(P)H oxidoreductase ubiquitously expressed in human cells.

    Proceedings of the National Academy of Sciences of the United States of America·1999
    Same author

    Regulation of the erythropoietin gene.

    Blood·1999
    Same author

    Oxygen sensing and signaling: impact on the regulation of physiologically important genes.

    Respiration physiology·1999
    Same author

    Inhibition of hypoxia-inducible factor 1 activation by carbon monoxide and nitric oxide. Implications for oxygen sensing and signaling.

    The Journal of biological chemistry·1999
    Same journal

    The use of granulocyte colony-stimulating factor in a neutropenic renal transplant recipient.

    Haematologia·2003
    Same journal

    Heterozygous methylene tetrahydrofolate reductase mutation with mild hyperhomocysteinemia associated with deep vein thrombosis.

    Haematologia·2003
    Same journal

    Congenital methemoglobinemia due to NADH-methemoglobin reductase deficiency in three Indian families.

    Haematologia·2003
    Same journal

    Angiocentric lymphomatoid granulomatosis and severe hypogammaglobulinaemia.

    Haematologia·2003
    Same journal

    Vena cava superior syndrome due to sternal plasmacytoma in the course of systemic myeloma.

    Haematologia·2003
    Same journal

    Hepatosplenic gamma delta T-cell lymphoma with leukemic phase successfully treated with 2-chlorodeoxyadenosine.

    Haematologia·2003
    See all related articles

    Area of Science:

    • Biochemistry
    • Clinical Chemistry
    • Pathophysiology

    Background:

    • Post-translational modifications of hemoglobin offer insights into metabolic health.
    • Nonenzymatic adducts form between hemoglobin and various small molecules in physiological and pathological states.
    • Hemoglobin glycosylation (HbA1c) is a well-understood modification elevated in diabetes.

    Purpose of the Study:

    • To explore the utility of hemoglobin as a reporter molecule for metabolic disorders.
    • To highlight the significance of hemoglobin adducts in disease monitoring and understanding.
    • To discuss various hemoglobin modifications beyond glycosylation.

    Main Methods:

    • Analysis of hemoglobin post-translational modifications.
    • Identification of adducts formed by small molecules like glucose, cyanate, and acetaldehyde.

    Related Experiment Videos

  • Correlation of modified hemoglobin levels with specific disease states.

    • Main Results:

    • Glycosylated hemoglobins (HbA1c) are elevated in diabetics, serving as a key monitoring tool.
    • Cyanate adducts are found in uremic patients, and acetaldehyde adducts in alcoholics.
    • Hemoglobin modifications reflect underlying metabolic perturbations.

    Conclusions:

    • Hemoglobin acts as a "reporter molecule" for metabolic disturbances.
    • Monitoring hemoglobin adducts can aid in diagnosing and managing metabolic disorders.
    • Non-enzymatic modifications of hemoglobin provide valuable diagnostic and prognostic information.